William Rosser Berry, MD

Publications

Tucker, Matthew D., Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, et al. “Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer..” Cancer Med, July 3, 2019. https://doi.org/10.1002/cam4.2375.

PMID
31270961
Full Text

Lagoo, Janaka, William R. Berry, Kate Miller, Brandon J. Neal, Luke Sato, Keith D. Lillemoe, Gerard M. Doherty, et al. “Multisource Evaluation of Surgeon Behavior Is Associated With Malpractice Claims..” Ann Surg 270, no. 1 (July 2019): 84–90. https://doi.org/10.1097/SLA.0000000000002742.

PMID
29578910
Full Text

Armstrong, Andrew J., Susan Halabi, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, et al. “Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study..” J Clin Oncol 37, no. 13 (May 1, 2019): 1120–29. https://doi.org/10.1200/JCO.18.01731.

PMID
30865549
Full Text

Petrylak, Daniel P., Philip Kantoff, Nicholas J. Vogelzang, Anthony Mega, Mark T. Fleming, Joe J. Stephenson, Richard Frank, et al. “Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer..” Prostate 79, no. 6 (May 2019): 604–13. https://doi.org/10.1002/pros.23765.

PMID
30663074
Full Text

Gupta, Shilpa, Luke T. Nordquist, Mark T. Fleming, William R. Berry, Jingsong Zhang, Sharon L. Ervin, Joel R. Eisner, Edwina S. Baskin-Bey, and Neal D. Shore. “Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer..” Clin Cancer Res 24, no. 21 (November 1, 2018): 5225–32. https://doi.org/10.1158/1078-0432.CCR-18-0564.

PMID
30012563
Full Text

Koontz, B. F., K. E. Hoffman, P. Healy, D. J. George, M. R. Harrison, T. Zhang, W. R. Lee, et al. “Two Year Outcomes of Short-Term Potent Androgen Blockade and Definitive Radiation for Intermediate to High Risk Localized Prostate Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 102:S100–S100. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.06.256.

Full Text

Berry, William R., Lizabeth Edmondson, Lorri R. Gibbons, Ashley Kay Childers, Alex B. Haynes, Richard Foster, Sara J. Singer, and Atul A. Gawande. “Scaling Safety: The South Carolina Surgical Safety Checklist Experience..” Health Aff (Millwood) 37, no. 11 (November 2018): 1779–86. https://doi.org/10.1377/hlthaff.2018.0717.

PMID
30395507
Full Text

Columbus, Alexandra B., Manuel Castillo-Angeles, William R. Berry, Adil H. Haider, Ali Salim, and Joaquim M. Havens. “An evidence-based intraoperative communication tool for emergency general surgery: a pilot study..” J Surg Res 228 (August 2018): 281–89. https://doi.org/10.1016/j.jss.2018.03.007.

PMID
29907223
Full Text

George, Daniel J., Elisabeth I. Heath, A Oliver Sartor, Guru Sonpavde, William R. Berry, Patrick Healy, Carolyn Winters, et al. “Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP)..” In Journal of Clinical Oncology, Vol. 36. AMER SOC CLINICAL ONCOLOGY, 2018.

Scholars@Duke

Forrester, J. A., L. A. Koritsanszky, D. Amenu, A. B. Haynes, W. R. Berry, S. Alemu, F. Jiru, and T. G. Weiser. “Developing Process Maps as a Tool for a Surgical Infection Prevention Quality Improvement Initiative in Resource-Constrained Settings.” Journal of the American College of Surgeons 226, no. 6 (June 1, 2018): 1103-1116.e3. https://doi.org/10.1016/j.jamcollsurg.2018.03.020.

Full Text

Pages